UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No. 1)
Filed by the Registrant (X)
Check the appropriate box:
( ) Preliminary Proxy Statement
( ) Confidential, for Use of the Commission Only (as permitted by
Rule 14a-6(e) (2)
(X) Definitive Proxy Statement
( ) Definitive Additional Materials
( ) Soliciting Material Pursuant to ss. 260.14a(11)(c) or ss. 240.14a-12
Sybron Chemicals Inc.
(Name of Registrant as Specified in its Charter)
N/A
(Name of Person(s) filing Proxy Statement if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
(X) No fee required
( ) Fee computed on table below per Exchange Act Rules 14a(6(i)(1) and 0-11.
(1) Title of each class of securities to which transaction applies:
N/A
(2) Aggregate number of securities to which transaction applies:
N/A
(3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):
N/A
(4) Proposed maximum aggregate value of transaction:
N/A
(5) Total fee paid:
N/A
( ) Fee paid previously with preliminary materials.
( ) Check box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee was
paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
(1) Amount Previously Paid:
(2) Form, Schedule or Registration Statement No.:
(3) Filing Party:
(4) Date Filed:
<PAGE>
SYBRON CHEMICALS INC.
Birmingham Road
Birmingham, New Jersey 08011
(609) 893-1100
___________________________
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON MAY 28, 1999
______________________________
The Annual Meeting of Stockholders of Sybron Chemicals Inc. (the "Company")
will be held on Friday, May 28, 1999, at 2:00 P.M. local time, at The Country
House, 122 South Pemberton Road, Pemberton, New Jersey 08068, for the following
purposes:
1. To elect one Class III Director to serve until the annual meeting of
Stockholders to be held in 2002 and until their successors shall be duly elected
and qualified.
2. To consider and act upon the selection of PricewaterhouseCoopers LLP as
the Company's independent auditors for the 1999 fiscal year.
3. To transact such other business as may properly come before the meeting
or any adjournment or postponement thereof.
The close of business on April 1, 1999 has been fixed as the record date
for the meeting. All stockholders of record at that time are entitled to notice
of and to vote at the meeting and any adjournment or postponement thereof.
All stockholders are cordially invited to attend the meeting. The Board of
Directors urges you to date, sign and return promptly the enclosed proxy to give
voting instructions with respect to your shares of Common Stock. This proxy is
solicited by the Board of Directors of the Company. The return of the proxy will
not affect your right to vote in person if you do attend the meeting. A copy of
the Company's Annual Report is also enclosed.
By Order of the Board of Directors,
STEVEN F. LADIN
Secretary
Birmingham, New Jersey
April 28, 1999
<PAGE>
SYBRON CHEMICALS INC.
Birmingham Road
Birmingham, New Jersey 08011
(609) 893-1100
________________________
PROXY STATEMENT
________________________
The enclosed proxy is solicited by the Board of Directors of Sybron
Chemicals Inc. (the "Company"), a Delaware corporation, for use at the Annual
Meeting of Stockholders (the "Meeting") to be held on Friday, May 28, 1999, at
2:00 P.M. local time, at The Country House, 122 South Pemberton Road, Pemberton,
New Jersey 08068, and any adjournment or postponement thereof. This proxy
statement, the foregoing notice and the enclosed proxy are being mailed to
stockholders on or about April 28, 1999.
The Board of Directors does not intend to bring any matters before the
Meeting other than the matters specifically referred to in the notice of the
Meeting, nor does the Board of Directors know of any matter which anyone else
proposes to present for action at the Meeting. However, if any other matters
properly come before the Meeting, the persons named in the accompanying proxy or
their duly constituted substitutes acting at the Meeting will be deemed
authorized to vote or otherwise act thereon in accordance with their judgment in
such matters.
In the absence of instructions, the shares represented at the Meeting by
the enclosed proxy will be voted "FOR" the nominee of the Board of Directors in
the election of one director; "FOR" the approval of PricewaterhouseCoopers LLP
as the Company's independent auditors for the 1999 fiscal year; and, as to any
other matter that may be properly brought before the Annual Meeting, in
accordance with the judgment of the proxy holders. Any proxy may be revoked at
any time prior to its exercise by notifying the Secretary in writing, by
delivering a duly executed proxy bearing a later date or by attending the
Meeting and voting in person.
QUORUM AND VOTING
The presence, in person or by proxy, of stockholders entitled to cast a
majority of the votes that stockholders are entitled to cast in the election of
a director and on the selection of PricewaterhouseCoopers LLP as the Company's
independent auditors, shall constitute a quorum. Each of those matters submitted
to the shareholders requires the affirmative vote of a majority of the
-1-
<PAGE>
votes cast at the meeting. For purposes of determining the number of votes
cast with respect to any voting matter, only those cast "for" or "against" are
included. Abstentions and broker non-votes are counted only for purposes of
determining whether a quorum is present at the Meeting.
At the close of business on April 1, l999, the record date, the Company had
outstanding 5,724,843 shares of Common Stock, par value $.0l per share. On all
matters voted upon at the Meeting and any adjournment or postponement thereof,
each record holder of Common Stock will be entitled to one vote per share.
PRINCIPAL STOCKHOLDERS
The following table sets forth certain information regarding the holdings
of each stockholder who was known to the Company to be the beneficial owner, as
defined in Rule 13d-3 under the Securities Exchange Act of 1934, of more than 5%
of the Company's Common Stock at the close of business on April 21, 1999. Each
of the persons named in the table below as beneficially owning the shares set
forth therein has sole voting power and sole investment power with respect to
such shares.
Amount Percent of
Beneficially Outstanding
Name and Address of Beneficial Owner Owned Shares*
399 Venture Partners, Inc................... 2,025,000(1) 35.20
Citibank, N.A.
Citicorp
399 Park Avenue
New York, NY 10043
Mario Joseph Gabelli........................ 1,148,600(2) 19.96
Gabelli Associates Fund
Gabelli Performance Partnership
One Corporate Center
Rye, NY 10580-1434
Richard M. Klein............................ 491,877(3) 8.81
P.O. Box 66
Birmingham, NJ 08011
Mentor Partners, L.P........................ 332,400(4) 5.78
499 Park Avenue
New York, NY 10022
*Based on outstanding shares as of March 15, 1999 as reported
on the Company's 10-K.
-2-
<PAGE>
(1) Based on a Schedule 13G/A, filed with the Securities and Exchange
Commission (the "Commission") as of February 10, 1999, which states that the
address of each of 399 Venture Partners, Inc. ("399 Venture"), Citibank, N.A.
("Citibank") and Citicorp is 399 Park Avenue, New York, New York 10043; that 399
Venture is the record and beneficial owner of 2,025,000 shares of Common Stock
and has sole ownership of and voting and dispositive powers over such shares;
that 399 Venture is a wholly owned subsidiary of Citibank; that Citibank is a
wholly owned subsidiary of Citicorp; and that Citibank and Citicorp own no
shares of Common Stock directly.
(2) Based on a Schedule 13D/A, filed with the Commission as of April 21,
1999 by Gamco Investors, Inc. ("GAMCO"), Gabelli Funds, LLC. ("GFL"), Gabelli
Associates Fund ("Gabelli Associates"), Gabelli International Limited ("GIL"),
Gabelli Performance Partnership L.P. ("GPP"), Gabelli Advisers, Inc. ("Gabelli
Advisers"), Gabelli Foundation, Inc. ("Foundation"),Gabelli Funds, Inc. ("GFI"),
Gabelli Asset Management, Inc. ("GAMI"), Marc J. Gabelli and Mario J. Gabelli,
which states that each of the following entities or individuals has sole voting
and dispositive power over the number of shares of the Company's Common Stock
listed next to its or his name: GAMCO -- 793,000 shares (13.78% of Common Stock
outstanding), GFL -- 263,000 shares (4.57% of Common Stock outstanding), Gabelli
Associates -- 9,500 shares (0.17% of Common Stock outstanding), GIL -- 42,000
shares (0.73% of Common Stock outstanding), GPP -- 33,400 shares (0.58% of
Common Stock outstanding), Gabelli Advisers -- 5,600 shares (0.1% of Common
Stock outstanding), Foundation -- 2,000 shares (.03% of Common Stock
outstanding), GFI -- 0 shares (0.0% of Common Stock outstanding), Marc J.
Gabelli -- 0 shares (0.0% of Common Stock outstanding), GAMI - 0 shares (0.0% of
Common Stock outstanding), Mario J. Gabelli -- 0 shares (0.0% of Common Stock
outstanding); that the address of GFI, GAMI, GAMCO, Gabelli Advisers and Gabelli
Associates is One Corporate Center, Rye, New York, 10580-1434, the address of
Foundation is 165 West Liberty Street, Reno, Nevada 89501, the address of GPP is
401 Theodore Fremd Ave., Rye, New York 10580, and the address of GIL is c/o
MeesPicrson (Cayman) Limited, British American Centre, Dr. Roy's Drive -- Phase
3, George Town, Grand Cayman, British West Indies; that the reporting persons do
not admit that they constitute a group; that Mario J. Gabelli is deemed to have
beneficial ownership of the shares owned beneficially by each of the reporting
persons other than Marc J. Gabelli; and that GFI and GAMI are deemed to have
beneficial ownership of the shares beneficially owned by each of the reporting
persons other than Mario J. Gabelli, Marc J. Gabelli and the Foundation.
(3) Shares issuable pursuant to options exercisable within 60 days of April
1, 1999 are deemed to be beneficially owned;
-3-
<PAGE>
accordingly, the amount beneficially owned by Richard M. Klein includes
16,500 shares of Common Stock underlying options held by him.
(4) Based on a Schedule 13F, filed with the Commission as of February 1,
1999, by Mentor Partners, L.P. ("Mentor") which states that the address of
Mentor is 500 Park Avenue, New York, New York 10022 and that Mentor owns
beneficially and has sole voting power and sole dispositive power over 332,400
shares of Common Stock.
MANAGEMENT OWNERSHIP
The following table sets forth certain information regarding the Common
Stock beneficially owned by the Company's Chief Executive Officer, by each
director and nominee for director of the Company, by each of the Company's four
other most highly compensated executive officers and by all directors and
executive officers of the Company as a group, at the close of business on March
15, 1999. Each of the persons named in the table below as beneficially owning
the shares set forth therein has sole voting power and sole investment power
with respect to such shares, unless otherwise indicated.
Amount Percent of
Beneficially Outstanding
Owned(1) Shares(1)
-------- ---------
Name of Beneficial Owner
- ------------------------
Richard M. Klein................................. 491,877 8.8
Kirk P. Pond.................................... 1,200 *
Fred P. Rullo, Jr............................... 0 *
Paul C. Schorr, IV............................... 3,720 *
John H. Schroeder................................ 74,543 1.3
Stephen R. Adler................................. 22,133 *
Peter de Bruijn. ............................... 16,961 *
Albert L. Eilender.............................. 17,829 *
All directors and executive officers as a
group (13 persons)............................. 636,054 11.1
__________________
*Represents less than 1% of the Company's outstanding shares of Common Stock.
(1) Shares issuable pursuant to options exercisable within
60 days of April 1, 1999 are deemed to be beneficially
owned; accordingly, the amount beneficially owned
includes the following number of shares of Common Stock
underlying options held by the following individuals:
Richard M. Klein 16,500 shares, Kirk. P. Pond 1,200
shares, Paul C. Schorr, IV 3,720, John H. Schroeder
15,300 shares, Stephen R. Adler 8,000 shares, Peter
de Bruijn 10,875 shares, and Albert L. Eilender 10,000
shares; and all directors and executive officers as a
group 68,620 shares.
-4-
<PAGE>
BOARD OF DIRECTORS AND COMMITTEES
The business of the Company is managed under the direction of its Board of
Directors. The Board meets on a regularly scheduled basis during the Company's
fiscal year to review significant developments affecting the Company and to act
on matters requiring Board approval. During the year ended December 31, 1998,
the Board of Directors met six times. During 1998, each of the directors was in
attendance at no less than 75% of the aggregate number of meetings of the Board
of Directors and the committees on which he served. The Company has the
following standing committees of the Board of Directors whose present members
are as identified below:
Audit and Compensation Committee. The Audit and Compensation Committee (the
"Committee") reviews and recommends to the Board of Directors the independent
auditors to be selected to audit the books of the Company and the proposed scope
of the audit to be performed by such independent auditors and reviews such
audit, including the opinion and any comments or recommendations of the
independent auditors. The Committee also reviews with the independent auditors
and with the financial management of the Company the adequacy and effectiveness
of the internal controls of the Company and reviews the practices and procedures
adopted by the Company to ensure compliance with the applicable laws and
regulations. In addition, the Committee approves the compensation of the
Executive Officers of the Company and serves as the Committee described in the
Company's 1992 Stock Option Plan to operate and administer the Plan solely with
respect to persons who are Principal Officers as defined therein. The Committee
met one time during 1998. The members of the Committee are Kirk P. Pond
(Chairman), Fred P. Rullo, Jr. and Paul C. Schorr, IV.
Stock Option Plan Committee. The Stock Option Plan Committee serves as the
Committee described in the Company's 1992 Stock Option Plan to operate and
administer the Plan solely with respect to persons who are not Principal
Officers as defined therein. The Stock Option Plan Committee did not meet during
1998. Its members are Richard M. Klein (Chairman) and John H. Schroeder.
Executive Committee. The Executive Committee was established to perform
such duties as the Board of Directors from time to time may direct. The
Executive Committee did not meet during 1998. Its members are Richard M. Klein
(Chairman), Paul C. Schorr, IV and John H. Schroeder.
Compensation of Directors
Each member of the Board of Directors who is not an employee of the Company
is automatically granted options to acquire 4,000
-5-
<PAGE>
shares of common stock on the first business day of each year at the
current market price. In addition, during 1998 directors of the Company who were
not employees or affiliates of Citicorp Investments Inc. were paid a standard
fee of (a) $750 for each meeting of the Board of Directors that such director
attends, and (b) $500 for each meeting of a committee of the Board of Directors
that such Director attends. Such Directors are also entitled to reimbursement of
reasonable travel expenses incurred while attending meetings of the Board of
Directors or any of its committees.
EXECUTIVE COMPENSATION
Summary Compensation Table
The following table summarizes certain information for each of the last
three fiscal years concerning the cash compensation paid by the Company, as well
as certain other compensation paid to or accrued for 1998, 1997 and 1996, to the
Company's Chief Executive Officer and to each of the Company's other four most
highly compensated executive officers:
<TABLE>
<CAPTION>
Annual Compensation Long Term Compensation
Awards
------------------------------------- --------------------------------------------
All
Other Other
Name and Annual Restricted Securities LTIP Compen-
Principal Salary Bonus Compensa- Stock Underlying Pay- sation
Position Year ($) ($) tion($) Award(s)($) Options outs($) ($)(4)
<S> <C> <C> <C> <C> <C> <C> <C> <C>
Richard M. Klein 1998 286,039 96,391(1) -- -- -- -- 45,154
President and Chief 1997 272,500 339,736(2) -- -- -- -- 36,416
Executive Officer 1996 264,560 176,959(3) -- -- 25,500 -- 23,931
Albert L. Eilender 1998 182,002 30,246(1) -- -- -- -- 21,564
Executive Vice 1997 204,000 181,442(2) -- -- -- -- 17,780
President, Corporate 1996 125,769 76,630(3) -- -- 25,000 -- 27,373
Development
John H. Schroeder 1998 175,449 41,877(1) -- -- -- -- 21,727
Executive Vice 1997 166,055 141,256(2) -- -- -- -- 18,968
President, 1996 158,795 79,037(3) -- -- 22,500 -- 15,646
Environmental
Products and Services
Peter de Bruijn 1998 138,792 33,847(1) -- -- -- -- 60,767
Managing Director- 1997 125,810 101,268(2) -- -- -- -- 60,359
Europe Division 1996 146,932 59,179(3) -- -- 10,625 -- 48,362
Stephen R. Adler 1998 101,328 19,734(1) -- -- -- -- 12,077
Vice President, 1997 96,967 62,236(2) -- -- -- -- 10,914
Human Resources 1996 93,333 10,256(3) -- -- 12,500 -- 9,038
</TABLE>
___________________
(1) Consists of bonuses earned during 1998 and paid in 1999
pursuant to the Company's Executive Bonus Plan (the "Bonus
Plan"). These bonuses were paid in the form of Common Stock
-6-
<PAGE>
and cash in the following amounts: Richard M. Klein 7,711
shares of Common Stock and $3 cash, Albert L. Eilender
2,419 shares of Common Stock and $8 cash, John H. Schroeder
3,350 shares of Common Stock and $2 cash, Peter de Bruijn
Bruijn 1,840 shares of Common Stock and $16,099 cash and
Stephen R. Adler 1,578 shares of Common Stock and $9 cash.
The closing price of the Common Stock on the date the Bonus
Plan shares were issued was $12.50. For a description of the
determination of the number of shares issued see: "Report of
the Audit and Compensation Committee on Executive
Compensation".
(2) Consists of bonuses earned during 1997 and paid in 1998
pursuant to the Company's Executive Bonus Plan (the "Bonus
Plan"). These bonuses were paid in the form of Common Stock
and cash in the following amounts: Richard M. Klein 6,856
shares of Common Stock and $108,346 cash, Albert L. Eilender
3,758 shares of Common Stock and $54,609 cash, John H.
Schroeder 2,639 shares of Common Stock and $52,190 cash,
Peter de Bruijn 708 shares of Common Stock and $77,373
cash and Stephen R. Adler 1,167 shares of Common Stock and
$25,850 cash. The closing price of the Common Stock on the
date the Bonus Plan shares were issued was $33.75. For a
description of the determination of the number of shares
issued see: "Report of the Audit and Compensation Committee
on Executive Compensation".
(3) Consists of bonuses earned during 1996 and paid in 1997
pursuant to the Company's Executive Bonus Plan (the "Bonus
Plan"). These bonuses were paid in the form of Common Stock
and cash in the following amounts: Richard M. Klein 4,276
shares of Common Stock and $103,198 cash, Albert L. Eilender
2,432 shares of Common Stock and $34,678 cash, John H.
Schroeder 1,381 shares of Common Stock and $55,215 cash,
Peter de Bruijn 635 shares of Common Stock and $48,225
cash and Stephen R. Adler 728 shares of Common Stock and
$24,677 cash. The closing price of the Common Stock on the
date the Bonus Plan shares were issued was $17.25. For a
description of the determination of the number of shares
issued see: "Report of the Audit and Compensation Committee
on Executive Compensation".
(4) Includes (with respect to amounts applicable to 1998) contri-
butions by the Company to the named executives' pension and
401(k) plans ("PLANS"), as well as car allowances ("AUTO"),
life insurance premiums ("LIFE"), supplemental executive
retirement plan contributions ("SERP") and income tax
preparation ("TAX") paid by the Company for the benefit of
the named executives: Richard M. Klein $13,996 (PLANS),
$2,503 (AUTO), $171 (LIFE), $27,755 (SERP), $729 (TAX);
Albert L. Eilender $9,861 (PLANS), $4,733 (AUTO), $547
(LIFE), $6,423 (SERP); John H. Schroeder $9,836 (PLANS),
$6,007 (AUTO), $547 (LIFE), $5,337 (SERP); Peter de Bruijn
-7-
<PAGE>
$52,892 (PLANS), $7,875 (AUTO); and Stephen R. Adler $8,630
(PLANS), $2,778 (AUTO), $462 (LIFE), $207 (SERP).
Stock Option Grants in Last Fiscal Year
No stock options were granted to the Chief Executive Officer and the four
most highly compensated other executive officers of the Company during 1998. The
Company did not grant any stock appreciation rights ("SARs") during 1998.
Aggregated Option Exercises in Last Fiscal Year and Fiscal Year-
End Option Values
During 1998, Albert L. Eilender exercised 5,000 options. None of the
Company's other executive officers exercised any of their stock options during
1998. The Company does not have any outstanding SARs.
<TABLE>
<CAPTION>
Number of Securities Value of Unexercised
Shares Underlying Unexercised In-the-Money Options
Acquired on Value Options at FY-End(#) at Fiscal Year-End
Name Exercise (#) Realized Exercisable Unexercisable Exercisable Unexercisable
<S> <C> <C> <C> <C> <C> <C>
Richard M. Klein 0 0 13,800 16,200 $4,500 $6,750
Albert L. Eilender 5,000 86,875 5,000 15,000 -- --
John H. Schroeder 0 0 12,600 14,400 4,500 6,750
Peter de Bruijn 0 0 9,475 12,525 3,400 5,100
Stephen R. Adler 0 0 7,000 8,050 1,750 2,625
</TABLE>
Compensation Committee Interlocks and Insider Participation
NONE
Pension Plans
None of the Company's executive officers are eligible participants in
defined benefit or actuarial plans sponsored by the Company. However, Peter de
Bruijn, a resident of the Netherlands, participates in a national pension plan
sponsored by the Dutch government.
Report of the Audit and Compensation Committee on Executive
Compensation.
The compensation policies adopted by the Audit and Compensation Committee
(the "Committee") are designed to attract and retain executives capable of
leading the Company to meet its
-8-
<PAGE>
business objectives, and to motivate the Company's executives to
enhance long term shareholder value.
The objectives of the Company's compensation program are to:
-attract, retain and motivate key executive talent; and
-provide rewards that are closely linked to Company
performance; and
-align the interests of the Company's key employees with
those of its stockholders through potential stock
ownership.
The Committee applies these objectives to executive officers and key
employees through the availability of performance based cash and stock incentive
opportunities and stock option grants.
Executive officer compensation programs have short-term and longer term
components. Short-term components include base salary and annual bonus under the
stockholder approved Executive Bonus Plan. The longer term component consists of
stock option awards under the 1992 Stock Option Plan and the stock award feature
of the annual bonus plan as described below.
Salaries
The Committee sets salaries for the Company's executive officers based upon
the Committee's assessment of the performance of each officer and the
Committee's understanding of executive compensation practices at similar
specialty chemical companies. The Committee uses industry comparative
compensation information as a general reference, however, rather than as a basis
for setting specific salary amounts.
Bonuses
Bonus awards for executive officers, which constitute a significant portion
of an executive's overall compensation, are determined in accordance with the
Company's Bonus Plan which provides for awards to executives based on meeting
operating profit growth targets.
Under the Bonus Plan, the bonus payable to certain executive officers for
any given year is based on the operating profit for that year versus targets
related to growth over the preceding year's operating profit as well as overall
growth of 12% per year in operating profit.
The basic bonus formula in the Bonus Plan provides for payments ranging
from 0% to 78% of the executive's base salary, depending on the executive's
salary grade level and on the level of operating profit attained in relation to
the targets, subject
-9-
<PAGE>
to certain adjustments based on the Company's cash flow
performance. In addition, executive officers may be entitled to
a supplemental bonus if operating profit exceeds the maximum
target level.
Dr. Klein and Messrs. Eilender, Schroeder, and Adler received 1998 bonuses
based on the executive officer basic bonus provisions of the Bonus plan. Each
received the same percentage payout relative to their grade level, in accordance
with the formula. Mr. de Bruijn received his bonus based on the Executive Basic
Bonus provisions of the Bonus Plan.
Executive officers received 100% of their 1998 Projected Target bonus in
Company Common Stock in accordance with the terms of the Bonus Plan. The number
of shares of Common Stock was based on each executive officer's 1998 Projected
Target (as defined in the Bonus Plan), at a pre-established historical price.
This price was $10.75 for Dr. Klein and Messrs. Adler, de Bruijn and Schroeder
and $14.25 for Mr. Eilender. The actual amount of each executive officer's stock
bonus for 1998 is based on the February 28, 1999 trading price of $12.50 per
share, which was 16.3% higher than the $10.75 price noted above, and 12.3% lower
than the $14.25 price noted above, and is used to calculate the number of shares
payable under the Bonus Plan.
In 1998 Dr. Klein and Messrs. Adler, de Bruijn, Eilender and Schroeder all
received merit increases in base salary on their salary review date.
AUDIT AND COMPENSATION COMMITTEE
OF THE BOARD OF DIRECTORS
Kirk P. Pond (Chairman)
Fred P. Rullo, Jr.
Paul C. Schorr, IV
Employment Agreements, Termination of Employment and Change-in-
Control Arrangements
Dr. Klein (President and Chief Executive Officer) is employed pursuant to
an employment agreement dated June 2, 1995 with the Company (the "Agreement").
The Agreement provides for an initial term of employment, which expired on
December 31, 1996, and for successive one year renewal periods subject to
termination as provided therein. The Agreement calls for compensation, benefits
and stock options to be paid to Dr. Klein as determined by the Audit and
Compensation Committee of the Company's Board of Directors.
The Agreement also provides that, in the event of a Change in Control (as
defined in the Agreement), Dr. Klein shall be entitled to a severance payment
equal to three times his annual
-10-
<PAGE>
base salary as then in effect, plus three times the average incentive
compensation awarded to Dr. Klein during the preceding calendar years, plus
one-half of Dr. Klein's base salary as then in effect in lieu of further
benefits and perquisites being provided by the Company to Dr. Klein. In
addition, Dr. Klein has the right to surrender to the Company for cancellation
all or any part of his options to purchase Common Stock of the Company in
exchange for an amount equal to the difference between the option prices for the
shares surrendered and the higher of (a) the fair market value to the shares
(determined to be the mean between the highest and lowest price for the shares
traded on the American Stock Exchange on the last trading day preceding the day
of surrender), or (b) the highest price per share offered to the Company's
shareholders in any tender or exchange offer which led to the Change in Control.
The Agreement subjects Dr. Klein to confidentiality obligations and certain
restrictions on competing with and soliciting customers of the Company for a
period of one year following termination of the Agreement.
Mr. Eilender (Executive Vice President, Corporate Development) is employed
pursuant to an employment agreement dated April 19, 1996 (the "Agreement"). The
Agreement provides that, if Mr. Eilender is terminated Without Cause, he would
be eligible for three months of salary continuation pay.
Mr. Schroeder (Executive Vice President, Environmental Products and
Services) is employed pursuant to an employment agreement which was amended and
restated in July 1995. The amended agreement provides that, upon the occurrence
of certain events (each a "Termination Event"), Mr. Schroeder shall be entitled
to be employed by the Company for a period of two years after the Termination
Event with remuneration, benefits and responsibilities comparable to those
earned prior to the Termination Event, or, at the Company's option, he shall be
entitled to receive, for a period of two years after the Termination Event,
payments equal to the base salary plus bonus earned by him prior to the
Termination Event.
Mr. Adler (Vice President, Human Resources) is employed pursuant to an
employment agreement dated February 13, 1998 (the "Agreement"). The Agreement
provides that, in the event there shall be a Change in Control (as defined in
the Agreement), and Mr. Adler's employment terminates Without Cause (as defined
in the Agreement) within 18 months of a Change of Control, he shall be entitled
to a lump sum payment equal to his annual base salary plus target Executive
Bonus.
-11-
<PAGE>
STOCK PERFORMANCE GRAPH
The following graph sets forth the cumulative total stock- holder return on
the Company's Common Stock from December 31, 1993 through December 31, 1998, as
compared to the returns of the Standard and Poor's Specialty Chemicals Stock
Index, Standard and Poor's Small Cap 600 Index and Standard and Poor's 500
Composite Index for the same period. The graph assumes $100 was invested on
December 31, 1993 in the Company's Common Stock and in each of the Standard and
Poor's indicies and assumes the reinvestment of dividends in each of the
Standard & Poor's indices. The Standard and Poor's Small Cap 600 Index has been
added because the Company believes that index is more indicative of its position
in the capital markets. The Company expects to drop the Standard and Poor's 500
Composite Index from the stock performance graph in future years.
GRAPH OMITTED
(See Below)
Comparison of Cumulative Total Returns
12/93 12/94 12/95 12/96 12/97 12/98
----- ----- ----- ----- ----- -----
Sybron Chemicals 100.00 64.25 44.56 66.32 138.86 55.96
S&P Small Cap 600 100.00 94.16 121.10 145.48 181.86 177.36
S&P Specialty Chemicals 100.00 85.73 110.90 118.71 144.50 116.05
S&P 500 Composite 100.00 98.46 132.04 158.80 208.04 263.52
-12-
<PAGE>
COMPLIANCE WITH SECTION 16(a) OF THE SECURITIES
EXCHANGE ACT OF 1934
Section 16(a) of the Securities Exchange Act of 1934, as amended, requires
the Company's officers and directors and persons who own more than ten percent
of a registered class of the Company's equity securities to file initial reports
of ownership and reports of changes in ownership with the Securities and
Exchange Commission and to furnish the Company with copies of these reports.
Based upon a review of such reports furnished to the Company, the Company
believes that all of those filing requirements were satisfied on a timely basis.
PROPOSAL ONE
ELECTION OF ONE DIRECTOR
At the Meeting, the stockholders will elect one Class III Director to hold
office until the Annual Meeting of Stockholders to be held in 2002 and until his
successor shall be duly elected and qualified. Proxies for holders of Common
Stock executed on the enclosed form will be voted, in the absence of other
instructions, "FOR" the election of the person named below. Should the nominee
become unavailable to accept nomination or election as a director, the persons
named in the enclosed proxy will vote the shares that they represent for the
election of such other person as the Board of Directors may recommend. The
nominee for director is presently serving as director of the Company.
The following sets forth certain information about the nominee for election
at this meeting and each director continuing in office.
Nominated for election at this meeting:
John H. Schroeder, 48, has served in various managerial positions within
the Company since 1983 and has been a director of the Company since February
1992. He was promoted to Executive Vice President, Environmental Products and
Services in March 1996 with responsibility for all business activities for the
Company's Environmental Products and Services segment. From February 1994 to
February 1996, he was the Executive Vice President, Ion Exchange Products.
Directors whose present terms continue until 2000:
Kirk P. Pond, 54, has been a director of the Company since May 1998. Mr.
Pond has been Chairman, President and CEO of Fairchild Semiconductor Corporation
of Portland, Maine and a member of the office of the President of National since
1994. He also served in various management positions for the combined
-13-
<PAGE>
National and Fairchild Logic businesses since 1984. Mr. Pond currently
serves as Chairman of Fairchild's Board of Directors.
Fred P. Rullo, Jr., 58, has been a director of the Company since February
1999. Mr. Rullo is currently Vice Chairman of Naxcor Biotech. He also was
chairman, President and CEO of Freedom Chemical Company. Prior to that he was
President of ABB Combustion Systems and Services, Executive Vice President and
Director of Lyondell Petrochemical Company, Senior Vice President of Arco
Chemical Company and was a director of Rexene Corporation. Mr. Rullo currently
serves as a director of Pecora Corporation and Carolina Best Friend Pet Care,
LLC.
Directors whose present term continues until 2001:
Paul C. Schorr, IV, 32, has been a director of the Company since February
1997. Mr. Schorr has been a Vice President of Citicorp Venture Capital Ltd.,
which is an affiliate of the Company, since 1996. Prior to joining Citicorp in
1996, Mr. Schorr was a consultant with McKinsey & Company, Inc. Mr. Schorr
currently serves as a director of Fairchild Semiconductor and KEMET Corporation.
Richard M. Klein, 61, has been a director of the Company and its President
and Chief Executive Officer since its inception in 1987. From 1969 until July
1987, Dr. Klein served in various managerial positions with the Company's
predecessors, becoming its senior executive officer in 1978. He holds a Ph.D. in
Chemistry from the University of Illinois. Dr. Klein currently serves as a
director of the Nash Engineering Company and Mannington Mills, Inc.
THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT
STOCKHOLDERS VOTE "FOR" THE NOMINEE FOR DIRECTOR
PROPOSAL TWO
PROPOSAL TO APPROVE THE APPOINTMENT OF INDEPENDENT AUDITORS
Subject to approval by the stockholders, the Board of Directors has
selected the firm of PricewaterhouseCoopers LLP, which served as the Company's
independent auditors for the last fiscal year, to serve as the Company's
independent auditors with respect to the consolidated financial statements of
the Company and its subsidiaries for the current fiscal year.
A representative of PricewaterhouseCoopers LLP is expected to be present at
the Annual Meeting and will have the opportunity to make a statement if he or
she desires to do so. The
-14-
<PAGE>
representative is also expected to be available to respond to appropriate
questions of stockholders.
THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT
STOCKHOLDERS VOTE "FOR" APPROVAL OF THE ABOVE PROPOSAL
STOCKHOLDER PROPOSALS
Stockholder proposals intended to be presented at the 2000 Annual Meeting
of Stockholders must be received by January 8, 2000 at the Company's principal
executive offices, Birmingham Road, Birmingham, New Jersey 08011, directed to
the attention of the Secretary in order to be considered for inclusion in next
year's annual meeting proxy material. Each proposal must set forth: (i) the name
and address of the stockholder who intends to bring the business before the
meeting; (ii) the general nature of the business which he or she seeks to bring
before the meeting; and (iii) a representation that the stockholder is a holder
of record of the stock of the Company entitled to vote at such meeting and
intends to appear in person or by proxy at the meeting to bring the business
specified in the notice before the meeting.
A stockholder of the Company may wish to have proposal presented at the
2000 Annual Meeting of Stockholders, but not to have such proposal included in
the Company's proxy statement and form of proxy relating to that meeting. If
notice of any such proposal (addressed to the Company at the address of the
Company set forth on the first page of this proxy statement) is not received by
the Company by March 15, 2000, then such proposal shall be deemed "untimely" for
purposes of Rule 14a-4(c) promulgated under the 1934 Act and, therefore, the
individuals named in the proxies solicited on behalf of the Board of Directors
of the Company for use at the Company's 2000 Annual Meeting of Stockholders will
have the right to exercise discretionary voting authority to such proposal.
SOLICITATION OF PROXIES
The accompanying form of proxy is being solicited on behalf of the Board of
Directors of the Company. The expenses of solicitation of proxies for the
Meeting will be paid by the Company. In addition to the mailing of the proxy
material, such solicitation may be made in person or by telephone or telecopy by
directors, officers or regular employees of the Company or its subsidiaries who
will not receive any additional compensation for such services.
-15-
<PAGE>
ANNUAL REPORT ON FORM l0-K
THE COMPANY WILL PROVIDE WITHOUT CHARGE TO EACH PERSON
SOLICITED BY THIS PROXY STATEMENT, ON THE WRITTEN REQUEST OF SUCH
PERSON, A COPY OF THE COMPANY'S ANNUAL REPORT ON FORM 10-K,
INCLUDING THE FINANCIAL STATEMENTS AND SCHEDULES THERETO, AS
FILED WITH THE SECURITIES AND EXCHANGE COMMISSION FOR ITS MOST
RECENT FISCAL YEAR. SUCH WRITTEN REQUESTS SHOULD BE DIRECTED TO
THE INVESTOR RELATIONS DEPARTMENT AT THE ADDRESS OF THE COMPANY
SET FORTH ON THE FIRST PAGE OF THIS PROXY STATEMENT.
The foregoing notice and proxy statement are sent by Order of the
Board of Directors.
/s/ Steven F. Ladin
-------------------
STEVEN F. LADIN
Secretary
April 28, 1999
-16-
<PAGE>
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF
SYBRON CHEMICALS INC.
The undersigned, a stockholder of SYBRON CHEMICALS INC., hereby constitutes
and appoints RICHARD M. KLEIN AND STEVEN F. LADIN, and each of them acting
individually, as the attorney and proxy of the undersigned, with full power of
substitution, for and in the name and stead of the undersigned, to attend the
Annual Meeting of Stockholders of the Company to be held on Friday, May 28,
1999, at 2:00 P.M. local time, at the Country House, 122 South Pemberton Road,
Pemberton, New Jersey 08068 and any adjournment or postponement thereof, and
thereat to vote all shares of Common Stock which the undersigned would be
entitled to cast if personally present, as follows on the reverse side.
THE UNDERSIGNED HEREBY ACKNOWLEDGES RECEIPT OF THE NOTICE OF ANNUAL
MEETING, PROXY STATEMENT AND ANNUAL REPORT OF SYBRON CHEMICALS INC.
CONTINUED AND TO BE SIGNED ON REVERSE SIDE
(See Reverse (See Reverse
Side) Side)
Please mark
(X) votes as in
this example
This Proxy is solicited on behalf of the Board of Directors. Unless otherwise
specified, the shares will be voted "FOR" the election of the nominee for
director and "FOR" the proposals set forth below. This Proxy also designates
discretionary authority to vote with respect to any other business which may
properly come before the Meeting or any adjournment or postponement thereof.
1. Election of a Director. 2. To approve the appointment of
PricewaterhouseCoopers LLP as
Nominee: John H. Schroeder the Company's independent auditors.
For Withheld For Withheld Abstain
( ) ( ) ( ) ( ) ( )
3. To vote on such other business
which may properly come before
the Meeting.
MARK HERE FOR ADDRESS CHANGE AND NOTE AT LEFT ( )
PLEASE SIGN, DATE AND RETURN IN THE ENCLOSED POSTAGE-PREPAID ENVELOPE.
NOTE: Please sign this Proxy exactly as name(s) appear in address. When
signing as attorney-in-fact, executor, administrator, trustee or guardian,
please add your title as such and if signer is a corporation, please sign with
full corporate name by duly authorized officer or officers and affix the
corporate seal. When stock is issued in the name of two or more persons, all
such persons should sign.
Signature:_______________ Date:______ Signature:_________________ Date:_______
